Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients

Nephrology Dialysis Transplantation

Volumn 21, Issue 10, 2006, Pages 2788-2794

  Gonçalves, Simone ^a,b   Pecoits Filho, Roberto ^a,b   Perreto, Sônia ^c   Barberato, Silvio H ^a,b,c   Stinghen, Andréa E M ^a   Lima, Emmanuel G A ^a   Fuerbringer, Roseana ^b   Sauthier, Sirlene M ^b   Riella, Miguel C ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b ProRenal Foundation   (Brazil)

^c Centro Paranaense de Ecocardiografia   (Brazil)

Author keywords

Cardiovascular disease; Endotoxin; Fluid overload; Glomerular filtration rate; Inflammation

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; ENDOTOXIN; FIBRINOGEN; UREA;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; ENDOTOXEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFERIOR CAVA VEIN; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; VEIN DIAMETER;

AGED; C-REACTIVE PROTEIN; CREATININE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ENDOTOXEMIA; ENDOTOXINS; FEMALE; FIBRINOGEN; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; KIDNEY; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED;

EID: 33749631245     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl273     Document Type: Article

References (31)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119
2. Cheung AK, Sarnak MJ, Yan G et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362
3. Sarnak MJ, Poindexter A, Wang SR et al. Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 2002; 62: 2208-2215
4. Longenecker JC, Coresh J, Powe NR et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol 2002; 13: 1918-1927
5. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126
6. Pecoits-Filho R, Lindholm B, Stenvinkel P. End-stage renal disease: A state of chronic inflammation and hyperleptinemia. Eur J Clin Invest 2003; 33: 527-528
7. Stenvinkel P. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease. J Ren Nutr 2003; 13: 144-148
8. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994; 45: 890-896
9. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001; 38: 85-90
10. Jager KJ, Merkus MP, Huisman RM et al. Nutritional status over time in haemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1272-1279
11. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169
12. Pinkau T, Hilgers KF, Veelken R, Mann JF. How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease? J Am Soc Nephrol 2004; 15: 517-523
13. Kooman JP, van der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms. Blood Purif 2004; 22: 55-59
14. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-890
15. Pecoits-Filho R, Goncalves S, Barberato SH et al. Impact of residual renal function on volume status in chronic renal failure. Blood Purif 2004; 22: 285-292
16. Sato Y, Takatsu Y, Kataoka K et al. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 1999; 22: 811-813
17. Cheriex EC, Leunissen KM, Janssen JH, Mooy JM, van Hooff JP. Echography of the inferior vena cava is a simple and reliable tool for estimation of 'dry weight' in haemodialysis patients. Nephrol Dial Transplant 1989; 4: 563-568
18. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-859
19. Oberg BP, McMenamin E, Lucas FL et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009-1016
20. Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92
21. Pecoits-Filho R, Heimburger O, Barany P et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-1218
22. Descamps-Latscha B, Herbelin A, Nguyen AT et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 1995; 154: 882-892
23. Pecoits-Filho R, Stenvinkel P, Wang AY, Heimburger O, Lindholm B. Chronic inflammation in peritoneal dialysis: The search for the holy grail? Perit Dial Int 2004; 24: 327-339
24. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 2003; 63: 654-661
25. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: No longer a simple plumbing problem. J Am Soc Nephrol 2003; 14: 1927-1939
26. Niebauer J, Volk H-d, Kemp M et al. Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 1999; 353: 1838-1842
27. Wang AY, Wang M, Woo J et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002; 62: 639-647
28. Katzarski KS, Charra B, Luik A et al. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transpl 1999; 14: 369-375
29. Anker SD, Coats AJ. Cardiac cachexia: A syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999; 115: 836-847
30. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241
31. Linnenweber S, Lonnemann G. Effects of dialyzer membrane on interleukin-1 beta (IL-1 beta) and IL-1 beta-converting enzyme in mononuclear cells. Kidney Int Suppl 2001; 78: S282-S285